Despite a wave of new therapies reshaping treatment across rare and glomerular kidney diseases, Alport syndrome has largely been left behind. Among kidney diseases evaluated by Spherix Global Insights ...

The Trump administration looks set to unveil a new slate of most favored nation (MFN) drug pricing deals with several ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The Nomura Small Cap Core Fund trailed its benchmark in Q2 2026 despite an exceptionally strong rally in small-cap stocks. Read the full analysis for more details.

Cytokinetics booked its first full quarter of MYQORZO sales on Aug. 6. Armistice Capital used the same three months to raise ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Eloxx Pharmaceuticals , Cingulate Inc and Agilon Health . 55% Off TipRanks. Unlock powerful inves ...

Travere Therapeutics Inc. company and executive profile by Barron's. View the latest TVTX company infomation and executive bios.

Inc. (Nasdaq: ODTX) (“Odyssey” or the “Company”), a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases ...

For 2Q26, Nomura Small Cap Growth Fund Institutional Class shares underperformed the Russell 2000 Growth Index.

Pricing for ETFs is the latest price and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you ...

Guardant Health stock tumbled Monday after losing a patent battle against privately held TwinStrand Biosciences.